113 related articles for article (PubMed ID: 24171521)
1. Myeloablation for lymphoma--question answered?
Milpied N
N Engl J Med; 2013 Oct; 369(18):1750-1. PubMed ID: 24171521
[No Abstract] [Full Text] [Related]
2. Do You Know Pixantrone?
Minotti G; Menna P; Salvatorelli E
Chemotherapy; 2017; 62(3):192-193. PubMed ID: 28334703
[No Abstract] [Full Text] [Related]
3. New therapeutic approaches to non-Hodgkin's lymphomas.
Lambert JF; Elfenbein GJ
Med Health R I; 2003 Aug; 86(8):236-9. PubMed ID: 14582217
[No Abstract] [Full Text] [Related]
4. [Treatment options in non-Hodgkin lymphomas].
Tilly H
Rev Prat; 2010 Jan; 60(1):69-74. PubMed ID: 20222315
[TBL] [Abstract][Full Text] [Related]
5. Extranodal lymphoma: a reappraisal.
Zucca E
Ann Oncol; 2008 Jun; 19 Suppl 4():iv77-80. PubMed ID: 18519412
[No Abstract] [Full Text] [Related]
6. High-dose etoposide plus granulocyte colony-stimulating factor as an effective chemomobilization regimen for autologous stem cell transplantation in patients with non-Hodgkin Lymphoma previously treated with CHOP-based chemotherapy: a study from the Consortium for Improving Survival of Lymphoma.
Hyun SY; Cheong JW; Kim SJ; Min YH; Yang DH; Ahn JS; Lee WS; Ryoo HM; Do YR; Lee HS; Lee JH; Oh SY; Suh C; Yhim HY; Kim JS
Biol Blood Marrow Transplant; 2014 Jan; 20(1):73-9. PubMed ID: 24141009
[TBL] [Abstract][Full Text] [Related]
7. Richter's syndrome: a novel presentation.
Smyth EF; Bartlett RJ; Shields ML; White TJ; Wengraf C
Ulster Med J; 2003 May; 72(1):58-60. PubMed ID: 12868708
[No Abstract] [Full Text] [Related]
8. CHOP versus CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma.
Alliot C
J Clin Oncol; 2005 Jul; 23(21):4797-9; author reply 4799-800. PubMed ID: 16034060
[No Abstract] [Full Text] [Related]
9. The development of pericarditis following peripheral blood stem cell transplantation: a case report.
Deaver D
Clin J Oncol Nurs; 2008 Apr; 12(2):201-5. PubMed ID: 18390456
[No Abstract] [Full Text] [Related]
10. [Non-Hodgkin's lymphoma: a new less toxic treatment doubles the prognosis].
Sabourin G
Perspect Infirm; 2012; 9(6):60. PubMed ID: 23234232
[No Abstract] [Full Text] [Related]
11. Clinical investigations in aggressive non-Hodgkin lymphoma.
Jonathan F
Clin Adv Hematol Oncol; 2008 Sep; 6(9):7-8. PubMed ID: 18998259
[No Abstract] [Full Text] [Related]
12. Advances in chemotherapy for large cell lymphoma.
Coleman M; Gerstein G; Topilow A; Lebowicz J; Berhardt B; Chiarieri D; Silver RT; Pasmantier MW
Semin Hematol; 1987 Apr; 24(2 Suppl 1):8-20. PubMed ID: 2438781
[TBL] [Abstract][Full Text] [Related]
13. High-dose cytarabine in mantle cell lymphoma.
Martin P
Clin Adv Hematol Oncol; 2015 Oct; 13(10):646-9. PubMed ID: 27058567
[No Abstract] [Full Text] [Related]
14. [Non-Hodgkin lymphoma of maxillofacial soft tissue: a report of two cases and review of the literature].
Chaabouni S; Ben Salah Lahiani H; Ghorbel L; Abdelmoula M; Elloumi M; Daoud J
Cancer Radiother; 2013 Jun; 17(3):229-32. PubMed ID: 23665292
[TBL] [Abstract][Full Text] [Related]
15. Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG).
Lenz G; Dreyling M; Hoster E; Wörmann B; Dührsen U; Metzner B; Eimermacher H; Neubauer A; Wandt H; Steinhauer H; Martin S; Heidemann E; Aldaoud A; Parwaresch R; Hasford J; Unterhalt M; Hiddemann W
J Clin Oncol; 2005 Mar; 23(9):1984-92. PubMed ID: 15668467
[TBL] [Abstract][Full Text] [Related]
16. Non-Hodgkin's lymphoma (diffuse large B cell lymphoma).
Copson E
Clin Evid; 2006 Jun; (15):30-44. PubMed ID: 16973004
[No Abstract] [Full Text] [Related]
17. Primary extranodal T-cell non-Hodgkin lymphoma of the tongue.
Madana J; Yolmo D; Saxena SK; Gopalakrishnan S
Ear Nose Throat J; 2012 Jan; 91(1):E1-3. PubMed ID: 22278870
[TBL] [Abstract][Full Text] [Related]
18. [Malignant lymphoma].
Hirano M
Nihon Naika Gakkai Zasshi; 1994 Mar; 83(3):363-7. PubMed ID: 7525807
[No Abstract] [Full Text] [Related]
19. [Anatomopathological and clinical aspects of primary gastric lymphoma].
Faraone V; Bartolo V; Calogero G; Maglitto D; La Malfa G; Briguglio M; Palmisano M; Di Mauro F
Ann Ital Chir; 1994; 65(1):75-9; discussion 80. PubMed ID: 7978750
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in patients with aggressive non-Hodgkin's lymphoma treated by front-line autotransplantation after complete remission: a cohort study by the Groupe d'Etude des Lymphomes de l'Adulte.
Mounier N; Gisselbrecht C; Brière J; Haioun C; Feugier P; Offner F; Recher C; Stamatoullas A; Morschhauser F; Macro M; Thieblemont C; Sonet A; Fabiani B; Reyes F;
J Clin Oncol; 2004 Jul; 22(14):2826-34. PubMed ID: 15254050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
